Top Stories
-
A new study has identified markers of maternal stress—both physical and psychological—that may influence a baby’s sex and the likelihood of preterm birth.
Topic
-
Columbia University experts explore the factors behind mass shootings and other forms of gun violence.
Topic
-
A new study eased fears about the proportion of youths with ADHD taking antipsychotic drugs but still found that many prescriptions may be inappropriate.
Topic
-
Deaths from suicide and overdose are left out of most estimates of maternal mortality, but in a new paper, Columbia researchers argue that these deaths represent a large and growing problem.
Topic
Latest News
- June 16, 2016
In cases of complicated grief, an antidepressant is useful for treating co-occurring depressive symptoms, a new Columbia study has found.
Topic
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Topic
- May 26, 2016
Researchers from Columbia and Finland report an association between maternal nicotine level during pregnancy and increased risk for schizophrenia in children.
Topic
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
Topic
- May 6, 2016
After a manic episode, adults with bipolar disorder are just as likely to experience anxiety as depression, finds a new Columbia Psychiatry study.
Topic
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Topic
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
Topic
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
Topic
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Topic
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Topic
